Latest Period
Q2 2026
Security Snapshot
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) Institutional Ownership
CUSIP: 53630X203
13F Institutional Holders and Ownership History from Q1 2021 to Q2 2026
Institutions Reporting
36
Shares (Excl. Options)
2,980,482
Price
$2.56
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- LPCN on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 2,980,482
- Total 13F value
- $7,628,833
- Portfolio coverage rank
- 0%
- Share change
- -137,924
- Value change
- -$5,140,869
- Number of holders
- 36
- Shares outstanding
- 8,265,306
- SEC-reported price per share
- $2.56
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- LPCN - Lipocine Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 53630X203.
- 36 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 46 to 36 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $24,916,198 to $7,628,833.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 36 institutions filings for Q2 2026.
Security key
53630X203
Latest holder period
Q2 2026
13F holders
36
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
LPCN full holder history
Lipocine Inc. SEC filings
Lipocine Inc. company facts
Lipocine Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 53630X203:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
LPCN
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Squadron Capital Management LLC | 9.8% | +60% | $2,079,432 | +$924,192 | 810,000 | +80% | Squadron Master Fund LP | 30 Jun 2026 |
| Ikarian Capital, LLC | 6.3% | $1,062,882 | 508,556 | Ikarian Capital, LLC | 31 Mar 2026 |
As of 30 Jun 2026, 36 institutional investors reported holding 2,980,482 shares of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN). This represents 36% of the company’s total 8,265,306 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
36%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Squadron Capital Management LLC | 9.8% | 810,000 | +80% | 0.71% | $2,073,600 |
| Ikarian Capital, LLC | 6.2% | 508,556 | 0% | 0.21% | $1,301,902 |
| Eversept Partners, LP | 3.6% | 294,989 | 0% | 0.04% | $755,172 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.8% | 230,823 | +15% | 0% | $590,907 |
| ACADIAN ASSET MANAGEMENT LLC | 2.1% | 170,417 | 0% | $435,000 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 1.7% | 140,487 | 0% | 0.01% | $359,647 |
| JANE STREET GROUP, LLC | 1.2% | 95,227 | +375% | 0% | $243,781 |
| BlackRock, Inc. | 1.1% | 89,272 | 0% | 0% | $228,536 |
| TWO SIGMA INVESTMENTS, LP | 1% | 84,887 | +152% | 0% | $217,311 |
| CITADEL ADVISORS LLC | 0.98% | 81,221 | +179% | 0% | $207,926 |
| Seven Fleet Capital Management LP | 0.95% | 78,842 | -37% | 0.03% | $201,836 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.9% | 74,477 | +18% | 0% | $190,761 |
| RENAISSANCE TECHNOLOGIES LLC | 0.84% | 69,209 | +80% | 0% | $177,175 |
| VANGUARD FIDUCIARY TRUST CO | 0.66% | 54,539 | +68% | 0% | $139,620 |
| DIMENSIONAL FUND ADVISORS LP | 0.44% | 36,775 | +92% | 0% | $94,144 |
| HRT FINANCIAL LP | 0.35% | 29,238 | 0% | $74,000 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.31% | 25,376 | +1.9% | 0% | $64,963 |
| STATE STREET CORP | 0.27% | 22,407 | 0% | 0% | $57,362 |
| GSA CAPITAL PARTNERS LLP | 0.23% | 18,666 | 0% | $48,000 | |
| Birchview Capital, LP | 0.2% | 16,712 | -85% | 0.02% | $42,783 |
| NORTHERN TRUST CORP | 0.19% | 15,942 | +22% | 0% | $40,812 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.15% | 12,266 | 0% | $32,000 | |
| BARCLAYS PLC | 0.12% | 9,827 | +4.4% | 0% | $25,157 |
| UBS Group AG | 0.04% | 3,596 | +2.9% | 0% | $9,206 |
| WELLS FARGO & COMPANY/MN | 0.03% | 2,706 | 0% | 0% | $6,927 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
17
Latest
Q2 2026
Rows shown
1-17 of 17
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 2,980,482 | $7,628,833 | -$5,140,869 | $2.56 | 36 |
| 2026 Q1 | 3,118,406 | $24,916,198 | +$11,788,932 | $7.99 | 46 |
| 2025 Q4 | 1,629,909 | $13,088,240 | +$4,710,434 | $8.03 | 25 |
| 2025 Q3 | 529,307 | $1,512,291 | +$2,462 | $2.85 | 21 |
| 2025 Q2 | 528,456 | $1,670,206 | +$34,959 | $3.16 | 18 |
| 2025 Q1 | 517,473 | $1,645,594 | +$97,947 | $3.18 | 19 |
| 2024 Q4 | 486,671 | $2,375,002 | -$289,398 | $4.88 | 17 |
| 2024 Q3 | 544,524 | $2,444,950 | +$9,929 | $4.49 | 18 |
| 2024 Q2 | 531,604 | $4,380,488 | +$476,120 | $8.24 | 18 |
| 2024 Q1 | 473,865 | $2,464,434 | -$16,115 | $5.20 | 17 |
| 2023 Q4 | 483,800 | $1,345,652 | -$46,888 | $2.78 | 18 |
| 2023 Q3 | 499,811 | $1,484,978 | -$7,404 | $2.97 | 20 |
| 2023 Q2 | 477,372 | $2,400,563 | +$2,397,563 | $5.03 | 22 |
| 2021 Q4 | 0 | $0 | -$1,090 | $2.56 | 0 |
| 2021 Q3 | 1,000 | $1,090 | $1.09 | 1 | |
| 2021 Q2 | 1,000 | $1,400 | $1.40 | 1 | |
| 2021 Q1 | 1,000 | $1,510 | +$1,510 | $1.51 | 1 |